115 related articles for article (PubMed ID: 30249891)
1. The analysis of deregulated expression of the
Wang F; Chen Q
J Cancer Res Ther; 2018 Sep; 14(Supplement):S708-S712. PubMed ID: 30249891
[TBL] [Abstract][Full Text] [Related]
2. Deregulated expression of the clock genes in gliomas.
Chen Z; Liu P; Li C; Luo Y; Chen I; Liang W; Chen X; Feng Y; Xia H; Wang F
Technol Cancer Res Treat; 2013 Feb; 12(1):91-7. PubMed ID: 22905804
[TBL] [Abstract][Full Text] [Related]
3. The analysis of deregulated expression and methylation of the PER2 genes in gliomas.
Fan W; Chen X; Li C; ; Chen L; Liu P; Chen Z
J Cancer Res Ther; 2014; 10(3):636-40. PubMed ID: 25313752
[TBL] [Abstract][Full Text] [Related]
4. Deregulated expression of cry1 and cry2 in human gliomas.
Luo Y; Wang F; Chen LA; Chen XW; Chen ZJ; Liu PF; li FF; Li CY; Liang W
Asian Pac J Cancer Prev; 2012; 13(11):5725-8. PubMed ID: 23317246
[TBL] [Abstract][Full Text] [Related]
5. Deregulated expression of the Per1 and Per2 in human gliomas.
Xia HC; Niu ZF; Ma H; Cao SZ; Hao SC; Liu ZT; Wang F
Can J Neurol Sci; 2010 May; 37(3):365-70. PubMed ID: 20481271
[TBL] [Abstract][Full Text] [Related]
6. Correlation between deregulated expression of PER2 gene and degree of glioma malignancy.
Wang F; Luo Y; Li C; Chen L
Tumori; 2014; 100(6):e266-72. PubMed ID: 25688509
[TBL] [Abstract][Full Text] [Related]
7. Identification of TIMELESS and RORA as key clock molecules of non-small cell lung cancer and the comprehensive analysis.
Xian H; Li Y; Zou B; Chen Y; Yin H; Li X; Pan Y
BMC Cancer; 2022 Jan; 22(1):107. PubMed ID: 35078435
[TBL] [Abstract][Full Text] [Related]
8. Potential cancer-related role of circadian gene TIMELESS suggested by expression profiling and in vitro analyses.
Mao Y; Fu A; Leaderer D; Zheng T; Chen K; Zhu Y
BMC Cancer; 2013 Oct; 13():498. PubMed ID: 24161199
[TBL] [Abstract][Full Text] [Related]
9. Aberrant TIMELESS expression is associated with poor clinical survival and lymph node metastasis in early-stage cervical carcinoma.
Zhang W; He W; Shi Y; Zhao J; Liu S; Zhang F; Yang J; Xie C; Zhang Y
Int J Oncol; 2017 Jan; 50(1):173-184. PubMed ID: 27909716
[TBL] [Abstract][Full Text] [Related]
10. Genetic and epigenetic associations of circadian gene TIMELESS and breast cancer risk.
Fu A; Leaderer D; Zheng T; Hoffman AE; Stevens RG; Zhu Y
Mol Carcinog; 2012 Dec; 51(12):923-9. PubMed ID: 22006848
[TBL] [Abstract][Full Text] [Related]
11. Dysregulation of Circadian Clock Genes as Significant Clinic Factor in the Tumorigenesis of Hepatocellular Carcinoma.
Liang Y; Wang S; Huang X; Chai R; Tang Q; Yang R; Huang X; Wang X; Zheng K
Comput Math Methods Med; 2021; 2021():8238833. PubMed ID: 34745328
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of p42.3 in low- and high-grade gliomas.
Wan W; Xu X; Jia G; Li W; Wang J; Ren T; Wu Z; Zhang J; Zhang L; Lu Y
World J Surg Oncol; 2014 Jun; 12():185. PubMed ID: 24927751
[TBL] [Abstract][Full Text] [Related]
13. TIMELESS confers cisplatin resistance in nasopharyngeal carcinoma by activating the Wnt/β-catenin signaling pathway and promoting the epithelial mesenchymal transition.
Liu SL; Lin HX; Lin CY; Sun XQ; Ye LP; Qiu F; Wen W; Hua X; Wu XQ; Li J; Song LB; Guo L
Cancer Lett; 2017 Aug; 402():117-130. PubMed ID: 28583847
[TBL] [Abstract][Full Text] [Related]
14. CREB3L1 and PTN expressions correlate with prognosis of brain glioma patients.
Liu LQ; Feng LF; Nan CR; Zhao ZM
Biosci Rep; 2018 May; 38(3):. PubMed ID: 29531016
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of centrosomal proteins at different stages of human glioma.
Loh JK; Lieu AS; Chou CH; Lin FY; Wu CH; Howng SL; Chio CC; Hong YR
BMC Cancer; 2010 Jun; 10():268. PubMed ID: 20529377
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of ubiquitin-specific protease 2a (USP2a) and nuclear factor erythroid 2-related factor 2 (Nrf2) in human gliomas.
Boustani MR; Khoshnood RJ; Nikpasand F; Taleshi Z; Ahmadi K; Yahaghi E; Goudarzi PK
J Neurol Sci; 2016 Apr; 363():249-52. PubMed ID: 27000259
[TBL] [Abstract][Full Text] [Related]
17. Systematic analysis of circadian genes in a population-based sample reveals association of TIMELESS with depression and sleep disturbance.
Utge SJ; Soronen P; Loukola A; Kronholm E; Ollila HM; Pirkola S; Porkka-Heiskanen T; Partonen T; Paunio T
PLoS One; 2010 Feb; 5(2):e9259. PubMed ID: 20174623
[TBL] [Abstract][Full Text] [Related]
18. Shugosin 2 is a biomarker for pathological grading and survival prediction in patients with gliomas.
Kao Y; Tsai WC; Chen SH; Hsu SY; Huang LC; Chang CJ; Huang SM; Hueng DY
Sci Rep; 2021 Sep; 11(1):18541. PubMed ID: 34535705
[TBL] [Abstract][Full Text] [Related]
19. A blood-based gene expression and signaling pathway analysis to differentiate between high and low grade gliomas.
Ponnampalam SN; Kamaluddin NR; Zakaria Z; Matheneswaran V; Ganesan D; Haspani MS; Ryten M; Hardy JA
Oncol Rep; 2017 Jan; 37(1):10-22. PubMed ID: 28004117
[TBL] [Abstract][Full Text] [Related]
20. Endothelin B receptor expression in malignant gliomas: the perivascular immune escape mechanism of gliomas.
Nakashima S; Sugita Y; Miyoshi H; Arakawa F; Muta H; Ishibashi Y; Niino D; Ohshima K; Terasaki M; Nakamura Y; Morioka M
J Neurooncol; 2016 Mar; 127(1):23-32. PubMed ID: 26645886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
